Join
Live feed
·
INSIDERFilingvia Quantisnow
TG Therapeutics Inc. logo

Director Lonial Sagar sold $432,889 worth of shares (25,933 units at $16.69) and was granted 22,250 shares, decreasing direct ownership by 3% to 105,195 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TGTX (TG Therapeutics Inc.) and more on Quantisnow.